Bone health and hyperglycemia in pediatric populations

被引:5
作者
Bilinski, Wojciech J. [1 ]
Paradowski, Przemyslaw T. [2 ,3 ]
Sypniewska, Grazyna [4 ]
机构
[1] KoMed, Dept Orthpaed, Poddebice, Poland
[2] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Orthopaed & Traumatol, Torun, Poland
[3] Umea Univ, Sunderby Res Unit, Div Orthoped, Dept Surg & Perioperat Sci, Umea, Sweden
[4] Nicolaus Copernicus Univ, Dept Lab Med, Coll Med Bydgoszcz, Torun, Poland
关键词
Bone turnover markers; reference ranges; hyperglycemia; diabetes; pediatric population; TYPE-1; DIABETES-MELLITUS; VITAMIN-D STATUS; I PROCOLLAGEN PINP; REFERENCE INTERVALS; TURNOVER MARKERS; INSULIN-RESISTANCE; AMINOTERMINAL PROPEPTIDE; BIOCHEMICAL MARKERS; MINERAL DENSITY; UNDERCARBOXYLATED OSTEOCALCIN;
D O I
10.1080/10408363.2020.1739619
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The impact of prediabetes and diabetes on skeletal health in the context of increased risk of fragility fractures in adults has been studied recently. However, the prevalence of diabetes, overweight, and obesity have also increased in younger subjects. Current data concerning bone metabolism based on assessment of markers for bone turnover and of bone quality in diabetes patients in diverse age groups appears to be inconsistent. This review synthesizes the current data on the assessment of bone turnover based on the use of circulating bone markers recommended by international organizations; the effects of age, gender, and other factors on the interpretation of the data; and the effects of type 1 and type 2 diabetes as well as hyperglycemia on bone quality and turnover with particular emphasis on the pediatric population. Early intervention in the pediatric population is necessary to prevent the progression of metabolic disturbances that accompany prediabetes and diabetes in the context of common low vitamin D status that may interfere with bone growth.
引用
收藏
页码:444 / 457
页数:14
相关论文
共 114 条
  • [1] Impaired glucose tolerance and bone mineral content in overweight Latino children with a family history of type 2 diabetes
    Afghani, A
    Cruz, ML
    Goran, MI
    [J]. DIABETES CARE, 2005, 28 (02) : 372 - 378
  • [2] Serum Concentrations of Insulin-like Growth Factor (IGF)-1 and IGF Binding Protein-3 (IGFBP-3), IGF-1/IGFBP-3 Ratio, and Markers of Bone Turnover: Reference Values for French Children and Adolescents and z-Score Comparability with Other References
    Alberti, Corinne
    Chevenne, Didier
    Mercat, Isabelle
    Josserand, Emilie
    Armoogum-Boizeau, Priscilla
    Tichet, Jean
    Leger, Juliane
    [J]. CLINICAL CHEMISTRY, 2011, 57 (10) : 1424 - 1435
  • [3] Effect of hemodialysis and renal failure on serum biochemical markers of bone turnover
    Alvarez, L
    Torregrosa, JV
    Peris, P
    Monegal, A
    Bedini, JL
    De Osaba, MJM
    Filella, X
    Martin, G
    Ricos, C
    Oppenheimer, F
    Ballesta, AM
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2004, 22 (03) : 254 - 259
  • [4] Assessment of Biochemical Bone Turnover Markers and Bone Mineral Density in Thin and Normal-Weight Children
    Ambroszkiewicz, Jadwiga
    Gajewska, Joanna
    Rowicka, Grazyna
    Klemarczyk, Witold
    Chelchowska, Magdalena
    [J]. CARTILAGE, 2018, 9 (03) : 255 - 262
  • [5] Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes
    Ardawi, Mohammed-Salleh M.
    Akhbar, Daad H.
    AlShaikh, Abdulrahman
    Ahmed, Maimoona M.
    Qari, Mohammed H.
    Rouzi, Abdulrahim A.
    Ali, Ahmed Y.
    Abdulrafee, Adel A.
    Saeda, Mamdouh Y.
    [J]. BONE, 2013, 56 (02) : 355 - 362
  • [6] Vitamin D status and ill health: a systematic review
    Autier, Philippe
    Boniol, Mathieu
    Pizot, Cecile
    Mullie, Patrick
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (01) : 76 - 89
  • [7] Reference values of osteocalcin and procollagen type I N-propeptide plasma levels in a healthy Central European population aged 0-18 years
    Bayer, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 (02) : 729 - 736
  • [8] Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials
    Bischoff-Ferrari, H. A.
    Dawson-Hughes, B.
    Staehelin, H. B.
    Orav, J. E.
    Stuck, A. E.
    Theiler, R.
    Wong, J. B.
    Egli, A.
    Kiel, D. P.
    Henschkowski, J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 : 843
  • [9] A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention
    Bischoff-Ferrari, Heike A.
    Willett, Walter C.
    Orav, Endel J.
    Lips, Paul
    Meunier, Pierre J.
    Lyons, Ronan A.
    Flicker, Leon
    Wark, John
    Jackson, Rebecca D.
    Cauley, Jane A.
    Meyer, Haakon E.
    Pfeifer, Michael
    Sanders, Kerrie M.
    Stahelin, Hannes B.
    Theiler, Robert
    Dawson-Hughes, Bess
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (01) : 40 - 49
  • [10] Simultaneous measurement of 25(OH)-vitamin D and 24,25(OH)2-vitamin D to define cut-offs for CYP24A1 mutation and vitamin D deficiency in a population of 1200 young subjects
    Cavalier, Etienne
    Huyghebaert, Loreen
    Rousselle, Olivier
    Bekaert, Anne-Catherine
    Kovacs, Stephanie
    Vranken, Laura
    Peeters, Stephanie
    Le Goff, Caroline
    Ladang, Aurelie
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (02) : 197 - 201